Ethyl (1S,2R)-1-{[(tert-butoxy)carbonyl]amino}-2-ethenylcyclopropane-1-carboxylate, 97.0%, 100mg

3-allyl-5,7-dimethylbenzo[d]thiazol-2(3H)-imine hydrobromide, 95.0%, 1g

2-Amino-6-chloropyrazine, 98.0%, 25g

2-Chloro-6-(trifluoromethyl)pyridin-4-amine, 95.0%, 25g

Bis(2,5-dioxopyrrolidin-1-yl) octanedioate, 95.0%, 1g

Petri dishes with aeration lugs, 145 x 20 mm, Sterile 120 pcs

3-(3-Trifluoromethyl-phenyl)-[1,2,4]oxadiazole-5-carboxylic acid ethyl ester, 95.0%, 5g

(R)-1-Methyl-5-oxopyrrolidine-2-carboxylic acid, 97.0%, 1g

(3aR,8aR)-N,N,2,2-Tetramethyl-4,4,8,8-tetraphenyltetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-amine, 98%, 1g

(5E)-5-(2,4-dimethylbenzylidene)-2-mercapto-1,3-thiazol-4(5H)-one, 95.0%, 1g

2-Bromo-6-fluoropyridin-3-ol, 95.0%, 10g

(3S)-3-Methyl-4-(6-nitro-3-pyridyl)morpholine, 98%, 500mg